 |
4 Products |  |
191 Diseases | | 4 Products |
|
9 Trials |  |
345 News |  |
| «123 |
- | NU-0129 / Northwestern University, Exicure
Enrollment open, Trial initiation date, Surgery: NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery (clinicaltrials.gov) - May 18, 2017
P, N=8, Recruiting, Sponsor: Northwestern University
Not yet recruiting --> Recruiting | Initiation date: Jan 2017 --> May 2017
- | Triapine (3-AP) / Vion, Northwestern University
Combination therapy, Metastases: NRG-GY006: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (clinicaltrials.gov) - May 17, 2017
P2, N=188, Suspended, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting | Initiation date: Jan 2017 --> May 2017 Recruiting --> Suspended
- | CLD-101 / Calidi Biotherap
Enrollment open, Oncolytic virus: Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma (clinicaltrials.gov) - Apr 25, 2017
P1, N=36, Recruiting, Sponsor: Northwestern University
Recruiting --> Suspended Not yet recruiting --> Recruiting
- | CLD-101 / Calidi Biotherap
New P1 trial, Oncolytic virus: Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma (clinicaltrials.gov) - Mar 7, 2017
P1, N=36, Not yet recruiting, Sponsor: Northwestern University
- | autologous hematopoietic stem cell therapy / Northwestern University
Trial completion: Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus (clinicaltrials.gov) - Jan 18, 2017
P1/2, N=25, Completed, Sponsor: University of Sao Paulo
Not yet recruiting --> Recruiting Recruiting --> Completed
- NU-0129 / Northwestern University, Exicure
New trial, Surgery: NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery (clinicaltrials.gov) - Jan 13, 2017
P0, N=8, Not yet recruiting, Sponsor: Northwestern University
- autologous hematopoietic stem cell therapy / Northwestern University
Enrollment closed: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy (clinicaltrials.gov) - Sep 19, 2016
P2, N=80, Active, not recruiting, Sponsor: Northwestern University
Recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change, Trial termination, Trial primary completion date: Hematopoietic Stem Cell Support in Vasculitis (clinicaltrials.gov) - Jul 13, 2016
P1, N=7, Terminated, Sponsor: Northwestern University
N=10 --> 7 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Jun 2016; No participant enrolled over five years. No plan to continue the study.
- autologous hematopoietic stem cell therapy / Northwestern University
Trial primary completion date: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy (clinicaltrials.gov) - Mar 22, 2016
P2, N=80, Recruiting, Sponsor: Northwestern University
No plan to continue the study. Trial primary completion date: Dec 2016 --> Dec 2017
- Trial primary completion date: Hematopoietic Stem Cell Support in Vasculitis (clinicaltrials.gov) - Mar 22, 2016
P1, N=10, Recruiting, Sponsor: Northwestern University
Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Aug 2016 --> Aug 2017
- Triapine (3-AP) / Vion, Northwestern University
Combination therapy, Metastases: NRG-GY006: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (clinicaltrials.gov) - Jan 26, 2016
P2, N=178, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Aug 2016 --> Aug 2017 Not yet recruiting --> Recruiting | Initiation date: Jun 2015 --> Jan 2016
- autologous hematopoietic stem cell therapy / Northwestern University
Enrollment change: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy (clinicaltrials.gov) - Sep 25, 2015
P2, N=80, Recruiting, Sponsor: Northwestern University
Not yet recruiting --> Recruiting | Initiation date: Jun 2015 --> Jan 2016 N=50 --> 80
- autologous hematopoietic stem cell therapy / Northwestern University
Enrollment change, Trial termination, Trial primary completion date: Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis (clinicaltrials.gov) - Sep 23, 2015
P1/2, N=2, Terminated, Sponsor: Northwestern University
N=50 --> 80 N=10 --> 2 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Aug 2015; No plan to continue enrollment
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Phase classification, Enrollment change: Stem Cell Transplantation for Stiff Person Syndrome (SPS) (clinicaltrials.gov) - Sep 22, 2015
P1/2, N=40, Recruiting, Sponsor: Northwestern University
N=10 --> 2 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Aug 2015; No plan to continue enrollment Phase classification: P1 --> P1/2 | N=10 --> 40
- autologous hematopoietic stem cell therapy / Northwestern University
Enrollment change, Trial withdrawal, Trial primary completion date: Hematopoietic Stem Cell Support Versus Insulin in T1D (clinicaltrials.gov) - Aug 21, 2015
P1/2, N=0, Withdrawn, Sponsor: Northwestern University
Phase classification: P1 --> P1/2 | N=10 --> 40 N=30 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Aug 2015
- | Triapine (3-AP) / Vion, Northwestern University
New P2 trial, Combination therapy, Metastases: NRG-GY006: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (clinicaltrials.gov) - Jun 9, 2015
P2, N=178, Not yet recruiting, Sponsor: National Cancer Institute (NCI)
- autologous hematopoietic stem cell therapy / Northwestern University
Trial primary completion date: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy (clinicaltrials.gov) - Apr 19, 2015
P2, N=50, Recruiting, Sponsor: Northwestern University
N=30 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Aug 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
New P1 trial: Stem Cell Transplantation for Stiff Person Syndrome (SPS) (clinicaltrials.gov) - Nov 4, 2014
P1, N=10, Recruiting, Sponsor: Northwestern University
- autologous hematopoietic stem cell therapy / Northwestern University
Trial primary completion date: Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis (clinicaltrials.gov) - Sep 28, 2014
P1/2, N=10, Recruiting, Sponsor: Northwestern University
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Dec 2015 --> Dec 2017
- Trial primary completion date: Hematopoietic Stem Cell Support in Vasculitis (clinicaltrials.gov) - Sep 28, 2014
P1, N=10, Recruiting, Sponsor: Northwestern University
Trial primary completion date: Dec 2015 --> Dec 2017 Trial primary completion date: Aug 2015 --> Aug 2016
- | Triapine (3-AP) / Vion, Northwestern University
Trial completion, Combination therapy: 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Aug 2015 --> Aug 2016 Active, not recruiting --> Completed
- autologous hematopoietic stem cell therapy / Northwestern University
Enrollment change: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy (clinicaltrials.gov) - May 17, 2012
P2, N=50, Recruiting, Sponsor: Northwestern University
Active, not recruiting --> Completed N=40 --> 50
- autologous hematopoietic stem cell therapy / Northwestern University
Trial termination: Crohn's Disease Stem Cell Transplantation (clinicaltrials.gov) - Apr 8, 2012
P2, N=1, Terminated, Sponsor: Northwestern University
N=40 --> 50 Active, not recruiting --> Terminated; The PI, who was sponsor got retired
- autologous hematopoietic stem cell therapy / Northwestern University
Enrollment change: Crohn's Disease Stem Cell Transplantation (clinicaltrials.gov) - Apr 8, 2012
P2, N=1, Terminated, Sponsor: Northwestern University
Active, not recruiting --> Terminated; The PI, who was sponsor got retired N=110 --> 1